Alzheimer’s Disease is the leading cause of dementia in older adults and its prevalence is increasing. Diagnosis of Alzheimer’s and other heterogenous neurodegenerative diseases is typically complex, disparate, and often completed late in disease progression. Evidation researchers, alongside researchers at Boston University School of Medicine, conducted a study that examined the use of voice recordings and transcripts as potential diagnostic tools for Alzheimer's Disease.
Other Good Reads:
Study: Decentralized and Remote Tech Increases Interest in Clinical Trial Participation | MobiHealthNews
The N-of-1 that Counts | Eric Daza, Evidation
What we’ve been up to:
Insights: Industry Survey - Integrated Evidence Strategies
In partnership with Fierce Biotech, Evidation is conducting a survey regarding integrated evidence strategies and the challenges pharmaceutical R&D and market access teams currently face incorporating and executing these strategies.
This survey only takes a few minutes and is an ideal opportunity for qualified professionals to provide their insights into the importance of the patient voice, how to build evidence strategies into the life cycle earlier, and get strategies integrated and optimized.
Announcement: Sensor Data Integrations Implementation Toolkit
Evidation is excited to share the Sensor Data Integrations Implementation Toolkit, a collection of open-access resources put together in partnership with Digital Medicine Society (DiMe) and leading industry organizations. This toolkit has the potential to help transform how health and disease are defined as well as increase our ability to make better decisions, faster, across patient care and clinical research.
2023 Planning: Roadmaps and Strategies for Success
Evidation’s experts are partnering with industry leaders to craft strategies that help accelerate patient activation, provide ongoing engagement, and deliver enriched, novel insights.
Are you working on your 2023 plans and strategies? Evidation has solutions to your biggest challenges.
Get To Know Your Evidation Team:
Prior to Evidation, Melanie was Senior Director, Insights and Analytics in Global Clinical Operations at Roche, and led Analytics at Genentech’s Commercial, Medical, and Government Affairs organization. She has also held several roles in marketing intelligence at an ad-tech start-up and in economics research at RTI International.
Melanie earned her Bachelor’s and Master’s degrees from North Carolina State University.
Outside of work, you can find Melanie spending time with her daughters Camille and Mirabel, and enjoying the live music offerings in the Bay Area.
Connect with Melanie here.